TYRON A ALLI
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology OMAHA, NE NPI 1447225784
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NE Regeneron Healthcare Solutions, Inc. All categories
General Payments — all program years on this page
$6,031.20
- Category: General Payments
- Program years: PY2018–2024
- Record count: 176
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,636.63 across 57 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,636.63 | 57 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $398.80 | 10 |
| ABBVIE INC. | $392.31 | 11 |
| Phathom Pharmaceuticals, Inc. | $391.22 | 5 |
| Gilead Sciences, Inc. | $382.88 | 8 |
| Janssen Biotech, Inc. | $261.79 | 4 |
| Ardelyx, Inc. | $168.37 | 3 |
| Lilly USA, LLC | $144.56 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $124.90 | 1 |
| GENZYME CORPORATION | $97.37 | 1 |
| PFIZER INC. | $70.76 | 1 |
| Madrigal Pharmaceuticals | $57.39 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $46.27 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $45.33 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.26 | 1 |
| QOL Medical, LLC | $19.64 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.78 | 1 |
By program year
Records — PY2024 (57)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.